Biotech · Public company · San Diego, CA, US

Dermata Therapeutics, Inc.

Ticker DRMA · SEC CIK 0001853816

Track this companyFree. Adds Dermata Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline3

DMT310-009 Topical in the Treatment of Acne VulgarisPHASE3 · COMPLETED · started Dec 8, 2023ClinicalTrials.gov NCT06090721 · fetched Nov 12, 2026
DMT310-005 Topical in the Treatment of Acne RosaceaPHASE2 · UNKNOWN · started Nov 15, 2021ClinicalTrials.gov NCT05108025 · fetched Nov 12, 2026
DMT310-003 Topical in the Treatment of Acne VulgarisPHASE2 · COMPLETED · started Oct 10, 2019ClinicalTrials.gov NCT04106778 · fetched Nov 12, 2026
DMT310-001 Topical in the Treatment of Acne VulgarisPHASE2 · COMPLETED · started May 22, 2018ClinicalTrials.gov NCT03536637 · fetched Nov 12, 2026